Stratos Wealth Partners, Ltd. Vertex Pharmaceuticals Inc Transaction History

Stratos Wealth Partners, Ltd.

$6.79 Billion
Q3 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 5,655 shares of VRTX stock, worth $2.55 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,655

Previous 5,717 1.08%

Holding current value

$2.55 Million

Previous $2.68 Million 1.83%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$460.0 - $505.78 $28,520 - $31,358	-62 Reduced 1.08%	5,655 $2.63 Million
Q2 2024 Jul 24, 2024	BUY	$392.81 - $485.53 $170,479 - $210,720	434 Added 8.22%	5,717 $2.68 Million
Q1 2024 Apr 16, 2024	BUY	$407.69 - $446.08 $879,387 - $962,194	2,157 Added 69.0%	5,283 $2.21 Million
Q4 2023 Jan 24, 2024	BUY	$343.0 - $410.68 $38,073 - $45,585	111 Added 3.68%	3,126 $1.27 Million
Q3 2023 Oct 24, 2023	SELL	$338.18 - $362.46 $116,333 - $124,686	-344 Reduced 10.24%	3,015 $1.05 Million
Q2 2023 Jul 18, 2023	BUY	$314.42 - $351.91 $74,517 - $83,402	237 Added 7.59%	3,359 $1.18 Million
Q1 2023 Apr 27, 2023	SELL	$283.23 - $323.1 $237,346 - $270,757	-838 Reduced 21.16%	3,122 $983,000
Q4 2022 Jan 19, 2023	BUY	$285.76 - $321.48 $194,602 - $218,927	681 Added 20.77%	3,960 $0
Q3 2022 Oct 24, 2022	BUY	$273.83 - $305.53 $56,135 - $62,633	205 Added 6.67%	3,279 $949,000
Q2 2022 Jul 22, 2022	BUY	$234.96 - $292.55 $46,052 - $57,339	196 Added 6.81%	3,074 $866,000
Q1 2022 Apr 26, 2022	BUY	$221.42 - $260.97 $50,483 - $59,501	228 Added 8.6%	2,878 $751,000
Q4 2021 Jan 14, 2022	SELL	$177.01 - $223.45 $50,093 - $63,236	-283 Reduced 9.65%	2,650 $582,000
Q3 2021 Oct 19, 2021	BUY	$181.39 - $202.99 $98,494 - $110,223	543 Added 22.72%	2,933 $532,000
Q2 2021 Jul 19, 2021	SELL	$187.49 - $221.1 $5,249 - $6,190	-28 Reduced 1.16%	2,390 $482,000
Q1 2021 Apr 27, 2021	BUY	$207.02 - $241.31 $195,840 - $228,279	946 Added 64.27%	2,418 $520,000
Q4 2020 Jan 29, 2021	BUY	$207.01 - $276.09 $16,146 - $21,535	78 Added 5.6%	1,472 $348,000
Q3 2020 Oct 29, 2020	SELL	$255.65 - $303.1 $163,871 - $194,287	-641 Reduced 31.5%	1,394 $379,000
Q2 2020 Jul 28, 2020	BUY	$225.48 - $295.8 $244,871 - $321,238	1,086 Added 114.44%	2,035 $591,000
Q1 2020 May 04, 2020	BUY	$199.77 - $247.81 $184,387 - $228,728	923 Added 3550.0%	949 $226,000
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $4,321 - $4,864	26 New	26 $322,000
Q4 2018 Feb 08, 2019	SELL	$151.91 - $192.21 $97,222 - $123,014	-640 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$167.73 - $192.74 $107,347 - $123,353	640 New	640 $123,000
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $111,330 - $129,849	-764 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$151.6 - $177.13 $38,961 - $45,522	-257 Reduced 25.17%	764 $125,000
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $140,162 - $158,816	1,021	1,021 $153,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Vertex Pharmaceuticals Inc Transaction History